nach oben

Zeitschrift für Rheumatologie

Erschienen in:

16.05.2022 | Originalien

Associations between anti-mitochondrial antibodies and cardiac involvement in idiopathic inflammatory myopathy patients

A systematic review and meta-analysis

verfasst von: Hui Wang, Yuan Zhu, Jingjing Hu, Jieni Jin, Jun Lu, Cong Shen, Zhaobin Cai, M.D.

Erschienen in: Zeitschrift für Rheumatologie | Sonderheft 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objectives of this study are to analyze the association between anti-mitochondrial antibody (AMA) and cardiac involvement in idiopathic inflammatory myopathy (IIM) and to evaluate the diagnostic value of AMA for cardiac involvement in IIM patients.

Methods

We conducted a comprehensive search in PubMed, Web of Science, EMBASE, and the Cochrane Library to identify English-language studies published before November 19, 2021. Stata 12.0 software (Stata Corp., College Station, TX, USA) was used for the statistical analyses. We used the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and summary receiver operating characteristic (SROC) curve to evaluate the diagnostic value of AMA for cardiac involvement in IIM patients. Statistical heterogeneity of studies was assessed using the I² statistic with 95% confidence intervals (95% CIs).

Results

Seven studies were included in the final analyses, with a total of 2308 IIM patients (including 171 AMA-positive and 2137 AMA-negative patients). The pooled sensitivity of AMA for cardiac involvement in IIM patients was 0.29 (95% CI: 0.19–0.43) and specificity was 0.92 (95% CI: 0.88–0.96). The pooled PLR was 3.9 (95% CI: 2.82–5.38), NLR was 0.76 (95% CI: 0.66–0.88), and the diagnostic odds ratio (DOR) was 5 (95% CI: 3–7). The area under the SROC curve was 0.76 (95% CI: 0.72–0.79).

Conclusion

The overall diagnostic value of AMA may not be very high for cardiac involvement in IIM patients.

Nur mit Berechtigung zugänglich

Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L (2018) Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement. Semin Arthritis Rheum 47:552–556. https://doi.org/10.1016/j.semarthrit.2017.06.004CrossRefPubMed

Behan WM, Behan PO, Gairns J (1987) Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins. Brit Heart J 57(2):176–180. https://doi.org/10.1136/hrt.57.2.176CrossRefPubMedPubMedCentral

Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344–347. https://doi.org/10.1056/NEJM197502132920706CrossRefPubMed

Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). New Engl J Med 292(8):403–407. https://doi.org/10.1056/NEJM197502202920807CrossRefPubMed

Dahlqvist G, Gaouar F, Carrat F, Meurisse S, Chazouillères O, Poupon R, Johanet C, Corpechot C (2017) Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis. Hepatology 65:152–163. https://doi.org/10.1002/hep.28859CrossRefPubMed

Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 83(1):35–42. https://doi.org/10.1097/01.md.0000109755.65914.5eCrossRefPubMed

Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38(5):705–713. https://doi.org/10.1002/ana.410380504CrossRefPubMed

Gupta R, Wayangankar SA, Targoff IN, Hennebry TA (2011) Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 148(3):261–270. https://doi.org/10.1016/j.ijcard.2010.08.013CrossRefPubMed

Højgaard PA-OX, Witting N, Rossing K, Pecini R, Hartvig Lindkær Jensen T, Hasbak P, Diederichsen LP (2021) Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy. Oxf Med Case Rep. https://doi.org/10.1093/omcr/omaa150CrossRef

10.

Huang Y, Liu H, Wu CA‑O, Fang L, Fang Q, Wang Q, Fei YA‑O, Guo X, Zhang S (2021) Ventricular arrhythmia predicts poor outcome in polymyositis/dermatomyositis with myocardial involvement. Rheumatology 60:3809–3816. https://doi.org/10.1093/rheumatology/keaa872CrossRefPubMed

11.

Kadosaka T, Tsujinaga S, Iwano H, Kamiya K, Nagai A, Mizuguchi Y, Motoi K, Omote K, Nagai T, Yabe I, Anzai T (2020) Cardiac involvement with anti-mitochondrial antibody-positive myositis mimicking cardiac sarcoidosis. ESC Heart Fail 7:4315–4319. https://doi.org/10.1002/ehf2.12984CrossRefPubMedPubMedCentral

12.

Khadilkar SV, Dhamne MC (2020) What is new in idiopathic inflammatory myopathies: mechanisms and therapies. Ann Indian Acad Neurol 23:458–467. https://doi.org/10.4103/aian.AIAN_400_19CrossRefPubMedPubMedCentral

13.

Konishi H, Fukuzawa K, Mori S, Satomi-Kobayashi S, Kiuchi K, Suzuki A, Yano Y, Yoshida A, Hirata KI (2017) Anti-mitochondrial M2 antibodies enhance the risk of supraventricular arrhythmias in patients with elevated hepatobiliary enzyme levels. Intern Med 56:1771–1779CrossRefPubMedPubMedCentral

14.

Lilleker JA‑O, Vencovsky JA‑O, Wang G, Wedderburn LR, Diederichsen LA‑O, Schmidt J, Oakley P, Benveniste O, Danieli MA‑O, Danko K, Thuy NTP, Vazquez-Del Mercado M, Andersson H, De Paepe B, deBleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge ZE, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77:30–39. https://doi.org/10.1136/annrheumdis-2017-211868CrossRefPubMed

15.

Liu XH, Feng XJ, Shi JY, Jia FW, Liu YX, Zhu YL, Li X, Wang YN, Huo L, Wang Q, Chen W (2020) The quest for diagnostic approaches of cardiac involvement in polymyositis and dermatomyositis. Ann Palliat Med 9:2256–2270. https://doi.org/10.21037/apm-19-650CrossRefPubMed

16.

Liu Y, Fang L, Chen W, Zhu Y, Lin X, Wang Y, Li X, Wang Q, Liu Z (2020) Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies. Cardiovasc Diagn Ther 10:405–420. https://doi.org/10.21037/cdt.2020.03.04CrossRefPubMedPubMedCentral

17.

Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Garcia-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O’Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG (2017) 2017 European league against rheumatism/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory Myopathies and their major subgroups. Ann Rheum Dis 76:1955–1964. https://doi.org/10.1136/annrheumdis-2017-211468CrossRefPubMed

18.

Maeda MH, Tsuji S, Shimizu J (2012) Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain 135:1767–1777. https://doi.org/10.1093/brain/aws106CrossRefPubMed

19.

Matsumoto K (2012) Successful steroid therapy for heart failure due to myocarditis associated with primary biliary cirrhosis. Can J Cardiol 28:515.e3–515.e6. https://doi.org/10.1016/j.cjca.2011.12.010CrossRefPubMed

20.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

21.

Opinc AA‑O, Makowski MA‑O, Łukasik ZA‑O, Makowska JA-OX (2021) Cardiovascular complications in patients with idiopathic inflammatory myopathies: does heart matter in idiopathic inflammatory myopathies? Heart Fail Rev 26:111–125. https://doi.org/10.1007/s10741-019-09909-8CrossRefPubMed

22.

Sabbagh SA‑O, Pinal-Fernandez I, Casal-Dominguez M, Albayda J, Paik JJ, Miller FW, Rider LG, Mammen AL, Christopher-Stine L (2021) Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis. Baillieres Clin Rheumatol 40:4095–4100CrossRef

23.

Schultheiss HP, Bolte HD (1985) Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 17(6):603–617. https://doi.org/10.1016/s0022-2828(85)80029-8CrossRefPubMed

24.

Schulze K, Becker BF, Schultheiss HP (1989) Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 64(2):179–192. https://doi.org/10.1161/01.res.64.2.179CrossRefPubMed

25.

Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL (2018) Classification and management of adult inflammatory myopathies. Lancet Neurol 17:816–828. https://doi.org/10.1016/S1474-4422(18)30254-0CrossRefPubMed

26.

Shimizu J (2013) Clinical and histopathological features of myositis associated with anti-mitochondrial antibodies. Rinsho Shinkeigaku 53:1114–1116. https://doi.org/10.5692/clinicalneurol.53.1114CrossRefPubMed

27.

Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626–636. https://doi.org/10.1067/mjd.2002.120621CrossRefPubMed

28.

Taborda AL, Azevedo P, Isenberg DA (2014) Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study. Clin Exp Rheumatol 32(2):188–193PubMed

29.

Uenaka T, Kowa H, Ohtsuka Y, Seki T, Sekiguchi K, Kanda F, Toda T (2017) Less Limb Muscle Involvement in Myositis Patients with Anti-Mitochondrial Antibodies. Eur Neurol 78(5–6):290–295.https://doi.org/10.1159/000481503CrossRefPubMed

30.

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM; QUADAS-2 Group (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Internal Med 155(8):529–536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009CrossRef

31.

Yamanaka T, Fukatsu T, Ichinohe Y, Hirata Y (2017) Antimitochondrial antibodies-positive myositis accompanied by cardiac involvement. BMJ Case Rep. https://doi.org/10.1136/bcr-2016-218469CrossRefPubMedPubMedCentral

32.

Zhang L, Yang H, Lei J, Peng Q, Yang H, Wang G, Lu X (2021) Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody. Semin Arthritis Rheum 51:741–748. https://doi.org/10.1016/j.semarthrit.2021.05.019CrossRefPubMed

33.

Zhang L, Zhu H, Yang P, Duan X, Wei W, Wu Z, Fang Y, Li Q, Liu S, Shi X, Li H, Wu C, Zhou S, Leng X, Zhao J, Xu D, Wu Q, Tian X, Li M, Zhao Y, Wang QA‑O, Zeng X (2021) Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry. Baillieres Clin Rheumatol 40:4597–4608. https://doi.org/10.1007/s10067-021-05828-yCrossRef

Titel: Associations between anti-mitochondrial antibodies and cardiac involvement in idiopathic inflammatory myopathy patients
A systematic review and meta-analysis
verfasst von: Hui Wang
Yuan Zhu
Jingjing Hu
Jieni Jin
Jun Lu
Cong Shen
Zhaobin Cai, M.D.
Publikationsdatum: 16.05.2022
Verlag: Springer Medizin
Erschienen in: Zeitschrift für Rheumatologie / Ausgabe Sonderheft 1/2024
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI: https://doi.org/10.1007/s00393-022-01216-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Associations between anti-mitochondrial antibodies and cardiac involvement in idiopathic inflammatory myopathy patients

A systematic review and meta-analysis

Abstract

Objective

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2024

Integrated comparison of the mRNAome in cartilage, synovium, and macrophages in osteoarthritis

Effects of exercise on depression in patients with rheumatic diseases: a systematic review and meta-analysis

Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany

Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients

Comparison of the efficacy and safety of olokizumab at different dosages in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials

Role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential biomarkers in Behçet’s disease: a meta-analysis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin